{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:00:55Z","timestamp":1778864455597,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Siksha 'O' Anusandhan Deemed To Be University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02021-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:24:49Z","timestamp":1770470689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4383-3109","authenticated-orcid":false,"given":"Susheel Kumar","family":"Yeshala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-1927","authenticated-orcid":false,"given":"Soumya Surath","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-0356","authenticated-orcid":false,"given":"Lalatendu","family":"Moharana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-7937","authenticated-orcid":false,"given":"SV","family":"Saju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-9574","authenticated-orcid":false,"given":"Krishnakumar","family":"Rathinam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-055X","authenticated-orcid":false,"given":"Susan Honey","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7100-8999","authenticated-orcid":false,"given":"Amit","family":"Sehrawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-7694","authenticated-orcid":false,"given":"Deepak","family":"Sundriyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin Oommen","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela Alice","family":"Kinsely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9732-3560","authenticated-orcid":false,"given":"Kanu Priya","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Dubashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunu Lazar","family":"Cyriac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathya","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7909-6844","authenticated-orcid":false,"given":"Lipsita","family":"Samantaray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-6293","authenticated-orcid":false,"given":"Swati Sucharita","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-783X","authenticated-orcid":false,"given":"Sudam","family":"Sadangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-6165","authenticated-orcid":false,"given":"Snehasis","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"2021_CR1","doi-asserted-by":"publisher","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21:389\u2013400. https:\/\/doi.org\/10.1038\/S41571-024-00881-3. Springer Nature. Cited 2025 Jul 24.","DOI":"10.1038\/S41571-024-00881-3"},{"key":"2021_CR2","unstructured":"Global Cancer Observatory. India Fact Sheet. Cancer Today. 2025. pp. 1\u20132."},{"key":"2021_CR3","doi-asserted-by":"publisher","unstructured":"Veneziani AC, Gonzalez-Ochoa E, Alqaisi H, Madariaga A, Bhat G, Rouzbahman M et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat Rev Clin Oncol. 2023;20:820\u201342. https:\/\/doi.org\/10.1038\/S41571-023-00819-1. Springer Nature. Cited 2025 Jul 24.","DOI":"10.1038\/S41571-023-00819-1"},{"key":"2021_CR4","doi-asserted-by":"publisher","unstructured":"Pignata S, Cecere SC, Du Bois A, Harter P, Heitz F. Treatment of recurrent ovarian cancer. Ann Oncol.2017;28:viii51\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdx441. Oxford University Press. Cited 2025 Jul 24.","DOI":"10.1093\/annonc\/mdx441"},{"key":"2021_CR5","doi-asserted-by":"publisher","unstructured":"Disilvestro P, Banerjee S, Colombo N, Scambia G, Kim BG, Oaknin A, et al. Overall survival with maintenance Olaparib at a 7-Year Follow-Up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: the SOLO1\/GOG 3004 Trial. J Clin Oncol. 2023.;41:609\u201317. https:\/\/doi.org\/10.1200\/JCO.22.01549. Lippincott Williams and Wilkins. Cited 2025 Jul 24.","DOI":"10.1200\/JCO.22.01549"},{"key":"2021_CR6","doi-asserted-by":"publisher","unstructured":"Monk BJ, Parkinson C, Lim MC, O\u2019malley DM, Oaknin A, Wilson MK, et al. A Randomized, phase III trial to evaluate Rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO\/GOG-3020\/ENGOT-ov45). J Clin Oncol. 2022;381:3952\u201364. https:\/\/doi.org\/10.1200\/JCO.22.01003. Lippincott Williams and Wilkins. Cited 2025 Jul 24.","DOI":"10.1200\/JCO.22.01003"},{"key":"2021_CR7","doi-asserted-by":"publisher","unstructured":"O\u2019Malley DM, Krivak TC, Kabil N, Munley J, Moore KN. PARP inhibitors in ovarian cancer: A Review. Target Oncol. 2023;18:471\u2013503. https:\/\/doi.org\/10.1007\/S11523-023-00970-W. Adis. Cited 2025 Jul 24.","DOI":"10.1007\/S11523-023-00970-W"},{"key":"2021_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13045-022-01360-X","volume":"15","author":"S Li","year":"2022","unstructured":"Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. J Hematol Oncol BioMed. 2022;15:1\u201332. https:\/\/doi.org\/10.1186\/S13045-022-01360-X. BioMed Central Ltd. Cited 2025 Jul 24.","journal-title":"J Hematol Oncol BioMed"},{"key":"2021_CR9","doi-asserted-by":"publisher","unstructured":"O\u2019Connor MJ. Targeting the DNA damage response in Cancer. Mol Cell. 2015;60:547\u201360. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.040. Cell Press. Cited 2025 Jul 24.","DOI":"10.1016\/j.molcel.2015.10.040"},{"key":"2021_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/J.EJCA.2016.03.005","volume":"60","author":"JA Ledermann","year":"2016","unstructured":"Ledermann JA, Drew Y, Kristeleit RS. Homologous recombination deficiency and ovarian cancer. Eur J Cancer. 2016;60:49\u201358. https:\/\/doi.org\/10.1016\/J.EJCA.2016.03.005. Pergamon. Cited 2025 Jul 24.","journal-title":"Eur J Cancer"},{"key":"2021_CR11","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMOA1910962","volume":"381","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2019","unstructured":"Gonz\u00e1lez-Mart\u00edn A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. New Engl J Med. 2019;381:2391\u2013402. https:\/\/doi.org\/10.1056\/NEJMOA1910962. Massachusetts Medical Society. Cited 2025 Jul 24.","journal-title":"New Engl J Med"},{"key":"2021_CR12","doi-asserted-by":"publisher","first-page":"A137","DOI":"10.1136\/IJGC-2022-IGCS.307","volume":"32","author":"J Ghosh","year":"2022","unstructured":"Ghosh J, Das C, Gogia A, Biswas G, Desai C, Rajpurohit S, et al. EP216\/#881\u2005Safety and tolerability of Olaparib in Indian patients with ovarian cancer: the prospective, single-arm, phase 4 soli trial. Int J Gynecol Cancer. 2022;32:A137. https:\/\/doi.org\/10.1136\/IJGC-2022-IGCS.307. Elsevier. Cited 2025 Jul 24.","journal-title":"Int J Gynecol Cancer Elsevier"},{"key":"2021_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/S10689-024-00429-5","author":"A Vatsyayan","year":"2024","unstructured":"Vatsyayan A, Anu RI, Mathur P, Uchil D, Joshi A, Dwivedi A, et al. BRCAIndica: a resource for ACMG\/AMP classified BRCA1 and BRCA2 variants. Fam Cancer. . 2024.24. https:\/\/doi.org\/10.1007\/S10689-024-00429-5. Fam Cancer. Cited 2025 Oct 31.","journal-title":"Fam Cancer"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02021-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02021-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02021-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:55:29Z","timestamp":1773222929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02021-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02021-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board (IMS.SH\/SOA\/2021\/097; Dated: 7th July 2021), and the patient\u2019s consent was obtained. All procedures performed in our study involving any human participation were in accordance with the ethical standards of the institutional and\/or national research committee and in compliance with the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all the patients for both participation and publication of the details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}